MyoKardia
Entity

  • MyoKardia

    Created in 2012
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    14,614

  • Activities

    healthtech biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    1000 Sierra Point Pkwy, Brisbane, CA 94005, USA

    Brisbane

    United States of America

  • Employees

    Scale: 201-500

    Estimated: 47

  • Engaged corporates

    1
    0 1

  • Added in Motherbase

    5 years, 11 months ago
Description
  • Value proposition

    Driven by the heart

    We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease.

    For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W

    Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D

  • Global Biopharmaceutical Company - Bristol Myers Squibb

    Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.

    • https://www.bms.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing 		Not capitalistic
Partnership
Not event

31 Jul 2021


Similar entities
Last news
Show all articles
Social network dynamics